FindTrial
Sign In

Effects of COVID-19 on postoperative respiratory failure in patients with lung cancer: a single-center, retrospective cohort study

Effects of COVID-19 on postoperative respiratory failure in patients with lung cancer: a single-center, retrospective cohort study

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2400086178
Enrollment
Unknown
Registered
2024-06-26
Start date
2024-07-01
Completion date
Unknown
Last updated
2024-07-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

lung cancer

Interventions

Grouping based on whether infected with COVID-19:None

Sponsors

Pulmonary Hospital Affiliated to Tongji University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
50 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Age 50-80 years old, gender unlimited. 2. Patients undergoing thoracoscopic surgery under elective general anesthesia. 3. Good lung function (FEV1=70%), able to tolerate single lung ventilation.

Exclusion criteria

Exclusion criteria: 1. No history of COVID-19 infection has been recorded.

Design outcomes

Primary

MeasureTime frame
Incidence of respiratory failure;—

Secondary

MeasureTime frame
Postoperative chest tube indentation days;IL-1ß, IL-6, IL-10, TNF-a inflammatory factors 1 to 3 days before and after surgery;Blood glucose, lactic acid, CRP 1-3 days before and after surgery;Intraoperative blood pressure, heart rate, oxygen saturation;Perioperative adverse reactions;Number of days in hospital after surgery;—

Countries

China

Contacts

Public ContactHong Shi

Pulmonary Hospital Affiliated to Tongji University

13651958255@139.com+86 136 5195 8255

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026